Abstract:Objective:To measure the choroidal thickness of patients with primary angle closure (PAC) before and after Nd:YAG laser peripheral iridotomy (LPI) using enhanced depth imaging spectral-domain optical coherence tomography (EDI-OCT);and to compare the difference between the choroidal thickness of patients with PAC and normal subjects.Methods:This was a prospective cohort study.Thirty patients (48 eyes) who were diagnosed with PAC were selected as the PAC group in the ophthalmology clinic of Shaoxing People's Hospital from October 2015 to February 2017.Thirty patients (50 eyes) undergoing regular physical examination were selected as normal controls in our hospital during the same period.Intraocular pressure and central anterior chamber depth were measured in the normal control group and PAC group before LPI,and 1 week,1 month,3 months and 6 months a~er LPI.Choroidal thickness was measured with EDI-OCT at the subfovea,as well as at 0.5,1.5 and 3.0 mm from the fovea superiorly,inferiorly,temporally,and nasally.Repeated measures ANOVA was used to compare data between the two groups at different time points,and to plot the choroidal thickness of the receiver operating characteristic curve to determine the best diagnostic limits.Pearson correlation analysis was used to assess the correlation among choroidal thickness,intraocular pressure and central anterior chamber depth.Independent t test was used to compare between the two groups.Results:The central anterior chamber depth of the PAC group was more shallow than that of the normal control group (t=-14.383,P＜0.001).The difference in central anterior chamber depth was statistically significant before LPI and 1 week,1 month,3 months and 6 months after LPI (F=10.313,P=0.001).And the central anterior chamber depth of the PAC group became deeper from preoperation to 3 months postoperation (P＜0.01).The choroidal thickness of the PAC group was greater than that of the normal control group at 13 points before LPI (all P ＜ 0.01).The difference in choroidal thickness was statistically significant before and after LPI (F=240.512,P＜ 0.001).The choroidal thickness of the PAC group at 1 week,1 month,3 months and 6 months after LPI was significantly thinner than that at pre-operation (P＜0.001).The choroidal thickness of all subjects in the two groups was negatively correlated with the depth of the central anterior chamber at SF,TI,T2,T3,S2,S3,I1,I2 and I3 (r=-0.249,-0.239,-0.416,-0.330,-0.184,-0.176,-0.189,-0.184,-0.160,P＜0.001).There was no correlation between choroidal thickness,intraocular pressure or axial length.Conclusions:The choroid in patients with PAC is thicker than in the normal group.The choroid in PAC patients became thinner after LPI surgery.Choroidal thickening may be one of the pathogenic factors of PACG.In addition,choroidal thickness plays a role in the early diagnosis of PAC and the disease observation and assessment of the therapeutic effect of LPI.

Influence of scleral thickness on photodynamic therapy outcomes in central serous chorioretinopathy

Subfoveal Choroidal Thickness after Photodynamic Therapy in Patients with Acute Idiopathic Central Serous Chorioretinopathy

Choroidal Vessel and Stromal Volumetric Analysis After Photodynamic Therapy or Focal Laser for Central Serous Chorioretinopathy

Threshold Thickness of Foveal Outer Nuclear Layer Associated with Outcomes of Photodynamic Therapy in Central Serous Chorioretinopathy

Clinical predictive factors and imaging biomarkers of treatment response to half dose PDT in patients with chronic central serous chorioretinopathy

Scleral thickness in simple versus complex central serous chorioretinopathy

Short-Term Retinal Sensitivity and Metamorphopsia Changes following Half-Fluence Photodynamic Therapy in Central Serous Chorioretinopathy

The Relationship Between Foveal Outer Nuclear Layer Thickness in the Active and Resolved Phases of Central Serous Chorioretinopathy Treated with Half-Dose Photodynamic Therapy

Risk factors of persistent subretinal fluid after half-dose photodynamic therapy for treatment-naïve central serous chorioretinopathy

Changes in the Foveal Outer Nuclear Layer of Central Serous Chorioretinopathy Patients over the Disease Course and Their Response to Photodynamic Therapy

Three-Year Follow-Up Detecting Choroidal Neovascularization with Swept Source Optical Coherence Tomography Angiography (SS-OCTA) after Successful Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

Evaluation of scleral thickness in patients with pterygium

Changes in Choroidal Thickness after Nd∶YAG Laser Peripheral Iridotomy in Patients with Primary Angle Closure

[Observation on Long-Term Efficacy of Half-Dose Photodynamic Therapy with Chronic Central Serous Chorioretinopathy Using Optical Coherence Tomography].

Longitudinal structural changes in central serous chorioretinopathy: A multimodal imaging-based study

Swept source optical coherence tomography and optical coherence tomography angiography in central serous chorioretinopathy

Pigment epithelial detachment composition indices in central serous chorioretinopathy as a biomarker for disease activity: A computational methodology and 1 year outcomes

Prognostic factors of visual outcome in central serous chorioretinopathy treated with subthreshold micropulse laser therapy

THE CLINICAL CORRELATION OF FUNDUS FLUORESCEIN ANGIOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY IN CENTRAL SEROUS CHORIORETINOPATHY

Importance of OCT-derived biomarkers for the recurrence of central serous chorioretinopathy using statistics and predictive modelling

Safety and Efficacy of Photodynamic Therapy with Chlorin E6 in Chronic Central Serous Chorioretinopathy